UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 23, 2012
EPOCRATES, INC.
(Exact name of registrant as specified in its charter)
Delaware | 001-35062 | 94-3326769 | ||
(State or other jurisdiction | (Commission File Number) | (IRS Employer Identification No.) | ||
of incorporation) | ||||
1100 Park Place, Suite 300 San Mateo, California | 94,403 | |
(Address of principal executive offices) | (Zip Code) | |
Registrant's telephone number, including area code: (650) 227-1700
Not Applicable
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On October 23, 2012, the Board of Directors of Epocrates, Inc. (the “Company”) appointed Andrew Hurd, the Company's President and Chief Executive Officer, as interim Chief Financial Officer, effective immediately. Mr. Hurd has served as the Company's President and Chief Executive Officer since March 2012 and will continue in this role.
Prior to joining the Company, Mr. Hurd served as Chairman and CEO of Carefx, a healthcare technology company acquired by Harris Corporation in 2011, from July 2005 to December 2011. There are no family relationships between Mr. Hurd and any director or executive officer of the Company, and he has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.
No new compensatory or severance arrangements were entered into in connection with Mr. Hurd's appointment as interim Chief Financial Officer.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
EPOCRATES, INC. | ||
Dated: October 24, 2012 | ||
By: | /s/ Matthew A. Kaminer | |
Matthew A. Kaminer | ||
General Counsel and Secretary | ||